Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Randomized controlled trial of a dose consolidation program.

Thomas Delate1, Kathleen A Fairman, Shelly M Carey

  • 1Express Scripts, Inc., Maryland Heights, Missouri 63043, USA. delatet@prodigy.net

Journal of Managed Care Pharmacy : JMCP
|September 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Race and Ethnicity With Computed Tomography Head Utilization in Children Presenting to the Emergency Department With an Unprovoked Seizure.

Pediatric neurology·2026
Same author

Warfarin Patient Self-Management in the US Health Care System: A Nonrandomized Clinical Trial.

JAMA network open·2026
Same author

Characterisation of real-world patients who discontinued a glucagon-like peptide-1 agonist.

Diabetes, obesity & metabolism·2026
Same author

Clinical and out-of-pocket cost outcomes after switching to biosimilar adalimumab-atto in patients with rheumatoid arthritis.

Expert opinion on biological therapy·2025
Same author

Overcoming Barriers to Warfarin Patient Self-Management (PSM) in the US Healthcare System: Implementation Trial Study Protocol.

medRxiv : the preprint server for health sciences·2025
Same author

Utilization Rates of Beneficial and Potentially Harmful Medications in the Outpatient Management of Chronic Kidney Disease.

The Senior care pharmacist·2025

A drug dose consolidation program using letters did not significantly reduce pharmacy costs. Factors like discontinuation and natural consolidation limited financial impact, suggesting limited effectiveness for this intervention.

Area of Science:

  • Health Economics
  • Pharmacy Management
  • Clinical Interventions

Background:

  • Inefficient medication dosing regimens represent a potential area for cost savings in healthcare.
  • Optimizing drug regimens can improve patient adherence and reduce overall healthcare expenditures.

Purpose of the Study:

  • To assess the effectiveness and financial impact of a drug dose consolidation program.
  • To evaluate a letter-based intervention aimed at optimizing medication dosing schedules.

Main Methods:

  • A randomized controlled trial was conducted in a mid-Atlantic health plan.
  • Prescribers with inefficient medication regimens received personalized letters detailing patient-specific issues and suggested optimizations.
  • Pharmacy claims were analyzed to determine regimen conversion rates and financial savings over 180 days.

Related Experiment Videos

Main Results:

  • The Physician/Member Letter arm showed a higher consolidation rate (10.2%) than the Physician Letter arm (7.3%) and the Control arm (3.9%).
  • Approximately 30% of targeted regimens were not refilled.
  • Financial modeling suggested minimal savings per member per month, even with full compliance.

Conclusions:

  • Letter-based dose consolidation programs did not appreciably decrease pharmacy expenditures.
  • High discontinuation rates and natural consolidation limited the intervention's financial benefits.
  • Few drug therapy classes showed significant potential for cost justification through dose consolidation.